BCR -

NYSE - NYSE Delayed Price. Currency in USD
0.00
0.00 (0.00%)
At close: 7:00PM EST
Stock chart is not supported by your current browser
Previous Close0.00
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Moody's2 months ago

    Moody's: Outlook for US medical products and devices industry changed to positive

    The outlook for the US medical products and devices industry has been revised upward, to positive from stable, Moody's Investors Service says in a just-published report. Continued product innovation and ...

  • Becton, Dickinson Ready to Sing a New Song
    Motley Fool3 months ago

    Becton, Dickinson Ready to Sing a New Song

    The addition of Bard will start paying off this year.

  • Benzinga4 months ago

    KeyBanc Initiates Becton, Dickinson And Co. With Bullish Stance

    Becton Dickinson and Co (NYSE: BDX ) was initiated with a top-notch rating by KeyBanc Capital Markets Thursday.  The Analyst KeyBanc analyst Matthew Mishan initiated coverage on Becton Dickinson with an ...

  • Moody's5 months ago

    C.R. Bard, Inc. -- Moody's withdraws C.R. Bard's ratings

    Rating Action: Moody's withdraws C.R. Global Credit Research- 02 Jan 2018. New York, January 02, 2018-- Moody's Investors Service, withdrew the Baa1 senior unsecured and Prime-2 short term ratings of C.R....

  • Market Realist5 months ago

    BD Gets Final Regulatory Approval for Bard Acquisition

    On December 28, Becton, Dickinson and Company (BDX), or BD, received clearance for its Bard (BCR) acquisition form MOFCOM (Ministry of Commerce of the People's Republic of China), but the approval is contingent ...

  • Capital Cube5 months ago

    ETFs with exposure to C.R. Bard, Inc. (New Jersey) : December 29, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to C.R. Bard, Inc. (New Jersey) Here are 5 ETFs with the largest exposure to BCR-US. Comparing the performance and risk of C.R. Bard, Inc. (New Jersey) with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)

  • Becton, Dickinson (BDX), Bard Receive Regulatory Nod in China
    Zacks5 months ago

    Becton, Dickinson (BDX), Bard Receive Regulatory Nod in China

    Favorable tidings on the regulatory front have boosted Becton, Dickinson and Company (BDX) lately. After the closure of the deal, the company will establish a new business segment.

  • Moody's5 months ago

    Becton, Dickinson and Company -- Moody's downgrades Becton, Dickinson and Company to speculative grade

    Rating Action: Moody's downgrades Becton, Dickinson and Company to speculative grade. Global Credit Research- 28 Dec 2017. New York, December 28, 2017-- Moody's Investors Service, today downgraded Becton, ...

  • NutriSystem (NTRI) Adopts Multi-Brand Strategy for 2018
    Zacks5 months ago

    NutriSystem (NTRI) Adopts Multi-Brand Strategy for 2018

    NutriSystem's (NTRI) Turbo Plans and South Beach Diet likely to witness an increase in customers.

  • Becton, Dickinson (BDX) a Step Closer to Bard Acquisition
    Zacks5 months ago

    Becton, Dickinson (BDX) a Step Closer to Bard Acquisition

    Becton, Dickinson and Company (BDX) gets FTC's nod for the acquisition of C. R. Bard.

  • Capital Cube5 months ago

    C.R. Bard, Inc. (New Jersey) – Value Analysis (NYSE:BCR) : December 26, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives C.R. Bard, Inc. (New Jersey) a score of 81. Our analysis is based on comparing C.R. Bard, Inc. (New Jersey) with the following peers – Boston Scientific Corporation, Teleflex Incorporated, Becton, Dickinson and Company, AngioDynamics, Inc., Merit Medical Systems, Inc., Medtronic plc, CryoLife, Inc., Hologic, Inc. and ... Read more (Read more...)

  • Capital Cube5 months ago

    ETFs with exposure to C.R. Bard, Inc. (New Jersey) : December 18, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to C.R. Bard, Inc. (New Jersey) Here are 5 ETFs with the largest exposure to BCR-US. Comparing the performance and risk of C.R. Bard, Inc. (New Jersey) with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)

  • Becton, Dickinson Banks on Bard Buyout, Medical Unit Weak
    Zacks5 months ago

    Becton, Dickinson Banks on Bard Buyout, Medical Unit Weak

    Becton, Dickinson (BDX) is steadily progressing with the acquisition of C. R. Bard. However, sluggishness in the Medical Segment is a headwind.

  • C.R. Bard, Inc. (New Jersey) : BCR-US: Dividend Analysis : December 08th, 2017 (record date) : By the numbers : December 8, 2017
    Capital Cube5 months ago

    C.R. Bard, Inc. (New Jersey) : BCR-US: Dividend Analysis : December 08th, 2017 (record date) : By the numbers : December 8, 2017

    Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing C.R. Bard, Inc. (New Jersey) with the following peers – Boston Scientific Corporation, Teleflex Incorporated, Becton, Dickinson and Company, AngioDynamics, Inc., Merit Medical Systems, Inc., Medtronic plc, CryoLife, Inc., Hologic, Inc. and CONMED Corporation (BSX-US, TFX-US, BDX-US, ANGO-US, MMSI-US, MDT-US, CRY-US, HOLX-US and CNMD-US). C.R. ... Read more (Read more...)

  • How Does C R Bard Inc’s (BCR) EPS Growth Stack Up Against Industry Performance?
    Simply Wall St.6 months ago

    How Does C R Bard Inc’s (BCR) EPS Growth Stack Up Against Industry Performance?

    When C R Bard Inc (NYSE:BCR) released its most recent earnings update (30 September 2017), I compared it against two factor: its historical earnings track record, and the performance ofRead More...

  • American City Business Journals6 months ago

    What Jabil's new director signals about the company's future

    Jabil Inc. has tapped a health care industry financial expert for a soon-to-be-vacant seat on its board of directors. Christopher Holland, senior vice president and chief financial officer of C.R. Bard Inc., was nominated to stand for election to the Jabil board in January, a press release said. C.R. Bard (BCR) is a Murray Hill, New Jersey-based medical technology firm.

  • Capital Cube6 months ago

    ETFs with exposure to C.R. Bard, Inc. (New Jersey) : November 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to C.R. Bard, Inc. (New Jersey) Here are 5 ETFs with the largest exposure to BCR-US. Comparing the performance and risk of C.R. Bard, Inc. (New Jersey) with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)

  • 3 Top Diabetes Stocks to Buy Now
    Motley Fool6 months ago

    3 Top Diabetes Stocks to Buy Now

    The diabetes market is growing. And these stocks are poised to grow with it.

  • Paul Tudor Jones: The Global Macro Trader
    GuruFocus.com6 months ago

    Paul Tudor Jones: The Global Macro Trader

    The guru hit home run after home run in the 20 years ending in 2007, but the last 10 years suggest that tape reading may not be an enduring strategy

  • Capital Cube6 months ago

    ETFs with exposure to C.R. Bard, Inc. (New Jersey) : November 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to C.R. Bard, Inc. (New Jersey) Here are 5 ETFs with the largest exposure to BCR-US. Comparing the performance and risk of C.R. Bard, Inc. (New Jersey) with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)

  • C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q3, 2017 By the Numbers : October 30, 2017
    Capital Cube7 months ago

    C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q3, 2017 By the Numbers : October 30, 2017

    Categories: Yahoo FinanceGet free summary analysis C.R. Bard, Inc. (New Jersey) reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of C.R. Bard, Inc. (New Jersey) – Boston Scientific Corporation, AngioDynamics, Inc. and Merit Medical Systems, Inc. (BSX-US, ANGO-US and MMSI-US) that have also reported for this ... Read more (Read more...)

  • Associated Press7 months ago

    C.R. Bard beats 3Q profit forecasts

    The Murray Hill, New Jersey-based company said it had net income of $1.25 per share. Earnings, adjusted for one-time gains and costs, came to $3.02 per share. The results beat Wall Street expectations. ...